Mutation Detection and Accurate Diagnosis of Extensively Drug-Resistant Tuberculosis: Report from a Tertiary Care Center in India

ABSTRACT We screened and spoligotyped 150 consecutive phenotypically confirmed extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) isolates (January 2008 to March 2009) for rifampin, isoniazid, fluoroquinolone, and aminoglycoside resistance targeting rpoB, inhA, katG, gyrA, gyrB, and rrs. Mutations predominant among XDR-TB were S315T (katG) (100% of isolates), S531L (rpoB) (97% of isolates), D94G (gyrA) (53% of isolates), and A1401G (rrs) (71% of isolates). Spoligotyping revealed 62% of the isolates to be Beijing.

[1]  S. Lawn,et al.  Extensively drug resistant tuberculosis , 2006, BMJ : British Medical Journal.

[2]  M. Makino,et al.  Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. , 1998, Journal of clinical microbiology.

[3]  B. Plikaytis,et al.  Mutation of tlyA Confers Capreomycin Resistance in Mycobacterium tuberculosis , 2005, Antimicrobial Agents and Chemotherapy.

[4]  Neel R Gandhi,et al.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2006, The Lancet.

[5]  M. Espinal,et al.  Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  M. Hui,et al.  Multiplex PCR Amplimer Conformation Analysis for Rapid Detection of gyrA Mutations in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates , 2004, Antimicrobial Agents and Chemotherapy.

[7]  S. Shenai,et al.  Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  Leen Rigouts,et al.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology , 2006, BMC Microbiology.

[9]  M. Behr,et al.  Extraction of Mycobacterium tuberculosis DNA: a Question of Containment , 2005, Journal of Clinical Microbiology.

[10]  V. Jarlier,et al.  Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes , 2006, Antimicrobial Agents and Chemotherapy.

[11]  A. Telenti,et al.  Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations , 1994, Antimicrobial Agents and Chemotherapy.

[12]  D. Soolingen.  Simultaneous detection and typing of Mycobacterium tuberculosis complex bacteria , 2005 .

[13]  H. Nikaido,et al.  Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra , 1996, Antimicrobial agents and chemotherapy.

[14]  Thomas M. Shinnick,et al.  Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis , 2005, Antimicrobial Agents and Chemotherapy.

[15]  G. Bai,et al.  Worldwide Emergence of Extensively Drug-resistant Tuberculosis , 2007, Emerging infectious diseases.

[16]  D. Soll,et al.  Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis , 1991, Journal of clinical microbiology.

[17]  I. Sugawara,et al.  Emergence of Ofloxacin Resistance in Mycobacterium tuberculosis Clinical Isolates from China as Determined by gyrA Mutation Analysis Using Denaturing High-Pressure Liquid Chromatography and DNA Sequencing , 2006, Journal of Clinical Microbiology.

[18]  A. Kaushik,et al.  Characterization of predominant Mycobacterium tuberculosis strains from different subpopulations of India. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[19]  A. Lalvani,et al.  High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Shenai,et al.  Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[21]  J. Perdigão,et al.  Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal. , 2010, The Journal of antimicrobial chemotherapy.

[22]  K. Kam,et al.  Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. , 2006, Microbial drug resistance.

[23]  G. Alangaden,et al.  Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients , 1995, Antimicrobial agents and chemotherapy.

[24]  M. Matee,et al.  A first insight into the genetic diversity of Mycobacterium tuberculosis in Dar es Salaam, Tanzania, assessed by spoligotyping , 2006, BMC Microbiology.

[25]  G. Alangaden,et al.  Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis , 1998, Antimicrobial Agents and Chemotherapy.

[26]  M. Tsukamura,et al.  Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis. , 1975, Journal of general microbiology.

[27]  Max Salfinger,et al.  The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis , 2001, Respiratory research.